RNA-TEC Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

RNA-TEC General Information

Description

Producer of synthetic DNA and RNA intended to identify the carriers of genetic information. The company's technology unmodified as well as with base and/or sugar modifications - and non-radioactive isotopically labeled (13C and 15N) nucleic acid products, enabling researches in the large research institutes and pharmaceutical companies to deal with RNA specific research.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Leuven
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RNA-TEC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 18-Sep-2006 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view RNA-TEC’s complete valuation and funding history, request access »

RNA-TEC Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
To view RNA-TEC’s complete investors history, request access »